Evidence map›Paper›PMID 29439968›Full record

ArticleAntimicrobial agents and chemotherapy2018

Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics.

Andrea Sass, Annelien Everaert, Heleen Van Acker, Freija Van den Driessche, Tom Coenye

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea SassLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Annelien EveraertLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Heleen Van AckerLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Freija Van den DriesscheLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium Tom.Coenye@Ugent.be.ORCID 0000-0002-6407-0601

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nonmevalonate pathway is the sole pathway for isoprenoid biosynthesis in

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamsBurkholderia cenocepaciaBurkholderia cepaciaMicrobial Sensitivity TestsMonobactamsPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsMonobactamsbeta-lactam antibioticsBurkholderia cenocepaciaBurkholderia cepacia complexDXRnonmevalonate pathway

Identifiers

PMID29439968
PMCPMC5923124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.